BMW's Share Price Slides Toward a 52-Week Floor as Recall Woes Compound a Brutal Earnings Season

BMW shares hit 52-week low as Q2 deliveries fall 4.9%, free cash flow drops 73.7%, and recalls hit motorcycles and EVs.

The pressure on BMW's stock is building from multiple directions at once. On Monday, shares in the Munich-based automaker slipped another 2.2 percent to €58.28, leaving the equity perched just 3.3 percent above the 52-week low of €56.40 set only weeks ago. The stock has now shed roughly 38 percent since the start of the year and trades a full 40 percent below its December 2025 peak.

That slide has unfolded against a backdrop of deteriorating fundamentals and fresh operational headaches. RBC Capital Markets added to the selling pressure on Friday when analyst Tom Narayan trimmed his price target on the ordinary shares from €62 to €60, while keeping a "Sector Perform" rating. Narayan pointed to a softening Chinese sales market and intensifying competitive pressure across Europe as the key reasons for his cautious stance — structural headwinds that show no sign of easing.

The numbers behind that skepticism make for grim reading. BMW delivered 590,947 vehicles in the second quarter, a 4.9 percent decline year-on-year and the third consecutive quarterly drop in deliveries. Revenue fell 7.9 percent to €31.259 billion, marking the tenth straight quarterly decline on the top line. Net profit tumbled 34.9 percent to €1.2 billion, with earnings per share sliding to €2.05 from €2.85 a year earlier. Most telling of all, free cash flow in the automotive segment collapsed 73.7 percent to just €513 million — a stark measure of how much cash the core business is generating after investments, and a figure that underscores just how much financial substance has eroded.

The operational challenges extend beyond the showroom. BMW Motorrad has concretized a worldwide recall affecting roughly 77,000 units of its S 1000 RR superbike from model years 2020 through 2026. A faulty ignition lock can trigger a sudden power loss, knocking out both the engine and ABS simultaneously — a safety defect serious enough to force customers into service bays. In parallel, reports have surfaced of a recall coordinated with Germany's Federal Motor Transport Authority covering electric models including the BMW i7, over potential fire risk. Faulty high-voltage battery cell modules could cause internal short circuits and overheating. For a manufacturer pushing hard into battery-electric vehicles with its "Neue Klasse" platform, the timing could hardly be worse.

Yet BMW is pressing ahead with its electrification strategy undeterred. On August 6, series production of the all-electric i3 sedan began at the main Munich plant — the second model built on the "Neue Klasse" architecture. The company estimates the new manufacturing setup delivers cost savings of around 10 percent compared with previous processes. A day earlier, pre-series production of sixth-generation high-voltage batteries kicked off at the new Irlbach-Straßkirchen facility, a site designed to churn out up to 600,000 batteries annually for the Neue Klasse — the very battery technology now drawing scrutiny in connection with the i7 recall. Management is holding firm to its target of cumulatively delivering 2 million fully electric vehicles by the end of 2026.

The technical indicators offer little comfort. The relative strength index sits at 42.7, neither oversold nor overbought, but reflective of persistently depressed sentiment toward the stock. Annualized volatility remains elevated at 23 percent. Technical analysts will be watching the €56.40 mark closely — a break below that level would confirm a fresh yearly low and potentially open the door to further downside.

Amid all this, BMW has quietly continued its share buyback program, acquiring 524,931 ordinary shares between August 10 and 16 at volume-weighted average prices ranging from €59.22 to €59.71 — levels that now sit above the current trading price. That buyback, while a signal of capital discipline, has done little to arrest the stock's decline.

The clustering of technical problems across both motorcycles and electric vehicles arrives at a delicate moment, as BMW funnels massive investment into new battery and manufacturing technology. The recalls themselves are unlikely to prove financially crippling, but they raise uncomfortable questions about quality assurance during a period of rapid transformation. Investors will be watching whether further costs or reputational damage emerge from these issues — and whether the €56.40 support level can hold in the sessions ahead.